Author

A. Ressa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Organism:human· 3 Assay:proteomics· 3 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

E. L. de Graaf· 2 shared A. F. M. Altelaar· 1 shared A. J. R. Heck· 1 shared A. Prahallad· 1 shared D. O. Debets· 1 shared E. Bosdriesz· 1 shared E. Cuppen· 1 shared E. Lips· 1 shared

Activity by Year

2017-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. L. de Graaf

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies

D. O. Debets, E. L. de Graaf, M. C. Liefaard, G. S. Sonke, E. Lips, A. Ressa, M. Altelaar

This study uses kinase activity profiling in HER2+ breast cancer biopsies to predict treatment outcomes and identify resistance mechanisms.

bioRxiv · Sep 23, 2022Cancer Biology

Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in GBM

F. Fabro, N. M. Kannegieter, E. L. de Graaf, K. Queiroz, M. L. M. Lamfers, A. Ressa, S. Leenstra

This study uses a novel kinase profiling platform to show drug efficacy and resistance in glioblastoma vary by patient and 2D/3D model.

bioRxiv · Jul 22, 2022Cancer Biology

A system-wide approach to monitor responses to synergistic BRAF and EGFR inhibition in colorectal cancer cells

A. Ressa, E. Bosdriesz, J. de Ligt, S. Mainardi, G. Maddalo, A. Prahallad, M. Jager, L. de la Fonteijne, M. Fitzpatrick, S. Groten, A. F. M. Altelaar, R. R. Bernards, E. Cuppen, L. Wessels, A. J. R. Heck

The paper investigates molecular responses to BRAF and EGFR inhibition in colorectal cancer cells, revealing metabolic shifts and MAPK pathway reactivation.

bioRxiv · Sep 27, 2017Cancer Biology